Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells

Molecular Biology Reports

Volumn 38, Issue 1, 2011, Pages 481-488

  Liu, Xiaoyan ^a   Lu, Guohong ^a   Shen, Jinfang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atherosclerosis; Chemokine; Dendritic cell; Epithelium

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR3R1; FRACTALKINE; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 4; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BASE PAIRING; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; IMMUNE RESPONSE; MALE; MONOCYTE; NONHUMAN; RAT; REVERSE TRANSCRIPTION;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; DENDRITIC CELLS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENE SILENCING; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE; RNA, SMALL INTERFERING; TRANSFECTION;

RATTUS;

EID: 78651081730     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0131-1     Document Type: Article

References (53)

1. K Takahashi M Takeya N Sakashita 2002 Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals Med Electron Microsc 35 179 203 1:CAS:528: DC%2BD38XpsFOmt7o%3D 10.1007/s007950200023 12658354 (Pubitemid 36205679)
2. AC Li CK Glass 2002 The macrophage foam cell as a target for therapeutic intervention Nat Med 8 1235 1242 1:CAS:528:DC%2BD38XotlWmu7w%3D 10.1038/nm1102-1235 12411950 (Pubitemid 35373554)
3. J Davignon P Ganz 2004 Role of endothelial dysfunction in atherosclerosis Circulation 109 III27 III32 15198963
4. GK Hansson 2005 Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 1685 1695 1:CAS:528:DC%2BD2MXjsFCltrc%3D 10.1056/NEJMra043430 15843671 (Pubitemid 40530235)
5. C Weber 2008 Chemokines in atherosclerosis, thrombosis, and vascular biology Arterioscler Thromb Vasc Biol 28 1896 1:CAS:528:DC%2BD1cXht1GgtbrO 10.1161/ATVBAHA.108.177311 18946056
6. Libby P, Aikawa M, Jain MK (2006) Vascular endothelium and atherosclerosis. Handb Exp Pharmacol 176:285-306
7. A Tedgui Z Mallat 2006 Cytokines in atherosclerosis: pathogenic and regulatory pathways Physiol Rev 86 515 581 1:CAS:528:DC%2BD28Xktlylu7g%3D 10.1152/physrev.00024.2005 16601268
8. H Loppnow K Werdan M Buerke 2008 Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms Innate Immun 14 63 87 1:CAS:528:DC%2BD1cXlsl2htrg%3D 10.1177/1753425908091246 18713724
9. LV Rao UR Pendurthi 2008 Factor VIIa binding to endothelial cell protein C receptor Thromb Res 122 Suppl 1 S3 S6 10.1016/S0049-3848(08)70009-4 18691496
10. E Galkina BL Harry A Ludwig EA Liehn JM Sanders A Bruce, et al. 2007 CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall Circulation 116 1801 1811 1:CAS:528:DC%2BD2sXhtFersLnI 10.1161/CIRCULATIONAHA.106.678474 17909108 (Pubitemid 350287105)
11. H Umehara ET Bloom T Okazaki Y Nagano O Yoshie T Imai 2004 Fractalkine in vascular biology: from basic research to clinical disease Arterioscler Thromb Vasc Biol 24 34 40 1:CAS:528:DC%2BD3sXhtVWhurvP 10.1161/01.ATV.0000095360.62479. 1F 12969992 (Pubitemid 38082409)
12. P Cockwell SJ Chakravorty J Girdlestone CO Savage 2002 Fractalkine expression in human renal inflammation J Pathol 196 85 90 1:CAS:528: DC%2BD38XhtFOhsL0%3D 10.1002/path.1010 11748646 (Pubitemid 34071583)
13. T Imaizumi H Yoshida K Satoh 2004 Regulation of CX3CL1/fractalkine expression in endothelial cells J Atheroscler Thromb 11 15 21 1:CAS:528:DC%2BD2cXjslOqtrs%3D 15067194
14. K Hatori A Nagai R Heisel JK Ryu SU Kim 2002 Fractalkine and fractalkine receptors in human neurons and glial cells J Neurosci Res 69 418 426 1:CAS:528:DC%2BD38XlslKksLw%3D 10.1002/jnr.10304 12125082 (Pubitemid 34809490)
15. SA Shulby NG Dolloff ME Stearns O Meucci A Fatatis 2004 CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells Cancer Res 64 4693 4698 1:CAS:528:DC%2BD2cXls1Oms7s%3D 10.1158/0008-5472.CAN-03-3437 15256432 (Pubitemid 38924507)
16. M Yoshikawa T Nakajima K Matsumoto N Okada T Tsukidate M Iida, et al. 2004 TNF-alpha and IL-4 regulate expression of fractalkine (CX3CL1) as a membrane-anchored proadhesive protein and soluble chemotactic peptide on human fibroblasts FEBS Lett 561 105 110 1:CAS:528:DC%2BD2cXhvFans7Y%3D 10.1016/S0014-5793(04)00132-2 15013759 (Pubitemid 38317304)
17. M Sans S Danese C de la Motte HS de Souza BM Rivera-Reyes GA West, et al. 2007 Enhanced recruitment of CX3CR1 + T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease Gastroenterology 132 139 153 1:CAS:528:DC%2BD2sXit1aqsLc%3D 10.1053/j.gastro.2006.10.010 17241867 (Pubitemid 46108734)
18. P Lesnik CA Haskell IF Charo 2003 Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis J Clin Invest 111 333 340 1:CAS:528:DC%2BD3sXpvFSnsw%3D%3D 12569158
19. C Combadiere S Potteaux JL Gao B Esposito S Casanova EJ Lee, et al. 2003 Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice Circulation 107 1009 1016 1:CAS:528:DC%2BD3sXjt1yjs78%3D 10.1161/01.CIR.0000057548.68243.42 12600915 (Pubitemid 36258725)
20. D Teupser S Pavlides M Tan JC Gutierrez-Ramos R Kolbeck JL Breslow 2004 Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root Proc Natl Acad Sci U S A 101 17795 17800 1:CAS:528:DC%2BD2MXjtVSntQ%3D%3D 10.1073/pnas.0408096101 15596719 (Pubitemid 40051966)
21. F Tacke D Alvarez TJ Kaplan C Jakubzick R Spanbroek J Llodra, et al. 2007 Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques J Clin Invest 117 185 194 1:CAS:528: DC%2BD2sXmvFSjsg%3D%3D 10.1172/JCI28549 17200718 (Pubitemid 46048465)
22. MI Cybulsky RA Hegele 2003 The fractalkine receptor CX3CR1 is a key mediator of atherogenesis J Clin Invest 111 1118 1120 1:CAS:528: DC%2BD3sXjtFCrsro%3D 12697729
23. P Ancuta R Rao A Moses A Mehle SK Shaw FW Luscinskas, et al. 2003 Fractalkine preferentially mediates arrest and migration of CD16 + monocytes J Exp Med 197 1701 1707 1:CAS:528:DC%2BD3sXkslCgtr0%3D 10.1084/jem.20022156 12810688 (Pubitemid 36745345)
24. CA Bursill KM Channon DR Greaves 2004 The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics Curr Opin Lipidol 15 145 149 1:CAS:528:DC%2BD2cXjslWqsbg%3D 10.1097/00041433-200404000-00007 15017357 (Pubitemid 38453402)
25. I Kawahara N Kitagawa K Tsutsumi I Nagata T Hayashi T Koji 2007 The expression of vascular dendritic cells in human atherosclerotic carotid plaques Hum Pathol 38 1378 1385 1:CAS:528:DC%2BD2sXpt1entbY%3D 10.1016/j.humpath.2007. 02.004 17555794 (Pubitemid 47247481)
26. XP Yang S Mattagajasingh S Su G Chen Z Cai K Fox-Talbot, et al. 2007 Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway Circ Res 101 1001 1008 1:CAS:528:DC%2BD2sXht1Kjs7bK 10.1161/CIRCRESAHA.107.160812 17885215 (Pubitemid 350084977)
27. EJ Papadopoulos C Sassetti H Saeki N Yamada T Kawamura DJ Fitzhugh, et al. 1999 Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation Eur J Immunol 29 2551 2559 1:CAS:528:DyaK1MXltFSltLo%3D 10.1002/(SICI)1521-4141(199908)29:08<2551::AID- IMMU2551>3.0.CO;2-T 10458770 (Pubitemid 29378126)
28. DH McDermott AM Fong Q Yang JM Sechler LA Cupples MN Merrell, et al. 2003 Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans J Clin Invest 111 1241 1250 1:CAS:528:DC%2BD3sXjtFCrs7Y%3D 12697743
29. S Apostolakis S Baritaki GE Kochiadakis NE Igoumenidis D Panutsopulos DA Spandidos 2007 Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease Thromb Res 119 63 71 1:CAS:528:DC%2BD28Xht1CgsL3I 10.1016/j.thromres.2005.12.016 16480760 (Pubitemid 44724920)
30. J Llodra V Angeli J Liu E Trogan EA Fisher GJ Randolph 2004 Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques Proc Natl Acad Sci U S A 101 11779 11784 1:CAS:528:DC%2BD2cXntVersrY%3D 10.1073/pnas.0403259101 15280540 (Pubitemid 39095371)
31. RL Lindquist G Shakhar D Dudziak H Wardemann T Eisenreich ML Dustin, et al. 2004 Visualizing dendritic cell networks in vivo Nat Immunol 5 1243 1250 1:CAS:528:DC%2BD2cXpvV2rsbo%3D 10.1038/ni1139 15543150 (Pubitemid 41057739)
32. J Jongstra-Bilen M Haidari SN Zhu M Chen D Guha MI Cybulsky 2006 Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis J Exp Med 203 2073 2083 1:CAS:528: DC%2BD28XptlSgs7w%3D 10.1084/jem.20060245 16894012 (Pubitemid 44352229)
33. SS Chan I McConnell BA Blacklaws 2002 Generation and characterization of ovine dendritic cells derived from peripheral blood monocytes Immunology 107 366 372 1:CAS:528:DC%2BD38Xpt1ent7g%3D 10.1046/j.1365-2567.2002.01515.x 12423313 (Pubitemid 35356957)
34. Cheng F, He S (2009) RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy. Mol Biol Rep
35. O Yoneda T Imai S Goda H Inoue A Yamauchi T Okazaki, et al. 2000 Fractalkine-mediated endothelial cell injury by NK cells J Immunol 164 4055 4062 1:CAS:528:DC%2BD3cXis1Wlu7w%3D 10754298
36. D Fox GJ Kouris KA Blumofe TJ Heilizer V Husak HP Greisler 1999 Optimizing fluorescent labeling of endothelial cells for tracking during long-term studies of autologous transplantation J Surg Res 86 9 16 1:CAS:528:DyaK1MXlt1WrsLs%3D 10.1006/jsre.1999.5597 10452862 (Pubitemid 29418481)
37. A Bender M Sapp G Schuler RM Steinman N Bhardwaj 1996 Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood J Immunol Methods 196 121 135 1:CAS:528:DyaK28XlsFWrtLs%3D 10.1016/0022-1759(96)00079-8 8841451 (Pubitemid 26306734)
38. G Esendagli A Gunel-Ozcan H Canpinar D Guc 2009 Molecular and functional analysis of a novel recombinant clone of rat (Rattus norvegicus) CD40 ligand (CD40L) gene Mol Biol Rep 36 83 89 1:CAS:528:DC%2BD1cXhtl2mu7rK 10.1007/s11033-007-9154-7 17922253
39. S Dichmann Y Herouy D Purlis H Rheinen P Gebicke-Harter J Norgauer 2001 Fractalkine induces chemotaxis and actin polymerization in human dendritic cells Inflamm Res 50 529 533 1:CAS:528:DC%2BD3MXos12msL8%3D 10.1007/PL00000230 11766992
40. S Goda T Imai O Yoshie O Yoneda H Inoue Y Nagano, et al. 2000 CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms J Immunol 164 4313 4320 1:CAS:528:DC%2BD3cXis1WksLg%3D 10754331
41. H Umehara S Goda T Imai Y Nagano Y Minami Y Tanaka, et al. 2001 Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1 Immunol Cell Biol 79 298 302 1:CAS:528: DC%2BD3MXltVGhtbo%3D 10.1046/j.1440-1711.2001.01004.x 11380684 (Pubitemid 32522179)
42. YV Bobryshev 2005 Dendritic cells in atherosclerosis: current status of the problem and clinical relevance Eur Heart J 26 1700 1704 10.1093/eurheartj/ ehi282 15855191 (Pubitemid 41219842)
43. P Liu YR Yu JA Spencer AE Johnson CT Vallanat AM Fong, et al. 2008 CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden Arterioscler Thromb Vasc Biol 28 243 250 1:CAS:528:DC%2BD1cXosVyntg%3D%3D 10.1161/ATVBAHA.107.158675 18079406 (Pubitemid 351161195)
44. CA Bolovan-Fritts SA Spector 2008 Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction Blood 111 175 182 1:CAS:528:DC%2BD1cXjtVKjtg%3D%3D 10.1182/blood-2007-08-107730 17895402
45. WL Jamieson S Shimizu JA D'Ambrosio O Meucci A Fatatis 2008 CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism Cancer Res 68 1715 1722 1:CAS:528:DC%2BD1cXjtFOhs7k%3D 10.1158/0008-5472.CAN-07-1315 18339851 (Pubitemid 351416556)
46. IF Tsai CY Lin CT Huang YC Lin CM Yang CH Liao 2007 Modulation of human monocyte-derived dendritic cells maturation by a soluble guanylate cyclase activator, YC-1, in a cyclic nucleotide independent manner Int Immunopharmacol 7 1299 1310 1:CAS:528:DC%2BD2sXosF2qsrY%3D 10.1016/j.intimp.2007.05.010 17673145 (Pubitemid 47126368)
47. M Rossi JW Young 2005 Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity J Immunol 175 1373 1381 1:CAS:528:DC%2BD2MXmtlWjsbg%3D 16034072
48. L Li L Huang SS Sung AL Vergis DL Rosin CE Rose Jr, et al. 2008 The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury Kidney Int 74 1526 1537 1:CAS:528: DC%2BD1cXhsVajtrbF 10.1038/ki.2008.500 18843253
49. A Yilmaz M Lochno F Traeg I Cicha C Reiss C Stumpf, et al. 2004 Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques Atherosclerosis 176 101 110 1:CAS:528:DC%2BD2cXmslersrw%3D 10.1016/j. atherosclerosis.2004.04.027 15306181 (Pubitemid 39078651)
50. C Erbel K Sato FB Meyer SL Kopecky RL Frye JJ Goronzy, et al. 2007 Functional profile of activated dendritic cells in unstable atherosclerotic plaque Basic Res Cardiol 102 123 132 1:CAS:528:DC%2BD2sXjs1Wis70%3D 10.1007/s00395-006-0636-x 17136419 (Pubitemid 46189953)
51. MT McManus PA Sharp 2002 Gene silencing in mammals by small interfering RNAs Nat Rev Genet 3 737 747 1:CAS:528:DC%2BD38XnsVGqs7k%3D 10.1038/nrg908 12360232
52. AM Adams SL Pratt SL Stice 2005 Knockdown of the Dnmt1 s transcript using small interfering RNA in primary murine and bovine fibroblast cells Mol Reprod Dev 72 311 319 1:CAS:528:DC%2BD2MXhtVGls7vE 10.1002/mrd.20357 16078273 (Pubitemid 41362095)
53. B Jagla N Aulner PD Kelly D Song A Volchuk A Zatorski, et al. 2005 Sequence characteristics of functional siRNAs RNA 11 864 872 1:CAS:528:DC%2BD2MXkvF2ktro%3D 10.1261/rna.7275905 15923373 (Pubitemid 40994197)